Sentences with phrase «of pediatric brain tumor»
C.S. Mott Children's Hospital has expertise in treating the full range of pediatric brain tumor types, including:
https://www.mottchildren.org/
Diagnostic technology for the post-operative monitoring of pediatric brain tumors, funded by Ente Cassa di Risparmio di Pisa
Not exact matches
Frustrated with the lack of investment in research and drug development devoted to pediatric brain tumor gliomas, the Kamens decided to take action and launch their foundation.
The Kamens claim the main thing that distinguishes their foundation from other brain tumor foundations is their focus on pediatric brain cancer specifically, as well as their close ties with pharmaceutical and biotech companies working in the fields of immunotherapy and target gene therapy.
In particular, our pediatric radiation oncologists at Floating Hospital for Children offer special expertise in the management of brain tumors, including medulloblastoma, with a combination of post-operative radiotherapy and multi-agent chemotherapy.
Engineered human immune cells can vanquish a deadly pediatric brain tumor in a mouse model, a study from the Stanford University School of Medicine has demonstrated.
Researchers from Northwestern Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago have revealed new insight into how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG), may develop.
«Carefully defining the molecular landscape of these tumor subtypes may guide us in pediatric precision medicine, to better treat children with brain tumors,» said Payal Jain, PhD, a postdoctoral researcher at Children's Hospital of Philadelphia (CHOP).
«Biology of childhood brain tumor subtypes offers clues to precision treatments: Researchers reveal differences among gene fusions in low - grade pediatric brain tumors.»
Researchers investigating pediatric low - grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer.
Previously, the authors of the study have shown that an experimental drug that inhibits polo - like kinase 4 (PLK4) stopped pediatric brain tumor growth in vitro.
«This is exciting because it's the first animal model of pediatric high - grade gliomas, or malignant brain tumors,» says Maria Castro, Ph.D., senior author of the paper and a professor in the departments of Neurosurgery and Cell and Developmental Biology at U-M.
She is studying the cell of origin that is responsible for the highly malignant pediatric brain tumor known as an Atypical Teratoid Rhabdoid Tumor (AT /tumor known as an Atypical Teratoid Rhabdoid Tumor (AT /Tumor (AT / RT).
My research program is centered around pediatric brain tumors and aims at elucidating genetic signatures of pediatric astrocytomas and examining how they compare to adults.
«We are very excited about this tumor model as it mimics the developmental environment of a pediatric or adolescent human brain tumor,» he says.
«His investigation of pediatric brain and spinal cord tumors is one of the innovative clinical - research efforts that advances the University of Chicago Hospitals to the forefront of medicine.»
Brain tumors are the most prevalent of any pediatric cancer (27 %), and certainly among the more lethal.
Its precision and safety makes it desirable for treatment of pediatric tumors and particularly tumors of the brain, spine, eye, lung, head and neck, and bone.
Screening of several other pediatric brain tumors revealed that the histone H3 mutations seem exclusive to pediatric high - grade gliomas.
UT Southwestern Medical Center's pediatric brain tumor team has dedicated subspecialists, state - of - the - art radiation technology, and access to advanced pediatric treatments that other hospitals in North Texas don't offer.
UT Southwestern's pediatric neurosurgeons are some of the most gifted neurosurgeons in the country and have, along with their colleagues in neuro - oncology, radiation oncology, and neuro - radiology, dedicated their lives to the care of children with brain tumors.
The University of Michigan is a national leader in basic, translational, and clinical research on pediatric brain tumors.
In this conference, members of the U-M pediatric brain tumor team and physicians from leading national brain tumor institutions incorporate molecular results from pediatric brain tumors (Mi - Oncoseq and molecular pathology) into targeted treatments for patients.
Our team combines patient - centered comprehensive care with state - of - the - art technology and research to provide the best possible outcomes for pediatric brain tumor patients.
Although brain tumors are still rare among the general pediatric population, about 20 % of all childhood cancers are brain tumors.
Our pediatric neurosurgeons use innovative intraoperative MRI technology to provide a detailed view of brain and spinal cord tumors during surgery.
Our groundbreaking Pediatric Mi - Oncoseq Program is an internationally known precision oncology program focusing on the genetic analysis of pediatric cancer patients including in children with malignant brain tumors, and determines whether targeted treatments may be available based upon their personalized tumor genomic sequencing profiles.
Dr. Biegel's primary research interests are focused on the genetics of pediatric rhabdoid tumors and childhood brain tumors.